AspenBio Pharma (APPY)

Recent filings

On November - Nov. 23, 2022

AspenBio Pharma Just Filed Its Annual Report: Income (loss) Per S... - Nov. 23, 2022

AspenBio Pharma Just Filed Its Quarterly Report: Income (Loss) Per Sh... - Nov. 7, 2022

AspenBio Pharma director just disposed of 26,000 shares - Nov. 1, 2022

AspenBio: Soliciting Material Under Section 240.14A-12 RIOT BLOCKCHAIN, INC. - Oct. 27, 2022

AspenBio: Soliciting Material Under Section 240.14A-12 RIOT BLOCKCHAIN, INC. - Oct. 25, 2022

AspenBio: Soliciting Material Under Section 240.14A-12 RIOT BLOCKCHAIN, INC. - Oct. 19, 2022

AspenBio Pharma director just disposed of 15,493 shares - Oct. 4, 2022

AspenBio Pharma director just disposed of 15,493 shares - Oct. 4, 2022

Chief Financial Officer - Oct. 3, 2022

Other definitive proxy statements - Oct. 3, 2022

Additional definitive proxy soliciting materials and Rule 14(a)(12) material - Oct. 3, 2022

AspenBio Pharma's Executive Chairman just picked up 3,398,518 shares - Sept. 29, 2022

AspenBio Pharma's Chief Financial Officer just picked up 404,289 shares - Sept. 29, 2022

SVP of AspenBio Pharma just picked up 320,586 shares - Sept. 29, 2022

AspenBio Pharma director just picked up 120,786 shares - Sept. 29, 2022

EVP of AspenBio Pharma just picked up 984,942 shares - Sept. 29, 2022

AspenBio Pharma's CFO (Former - See Remarks) just picked up 546,217 shares - Sept. 29, 2022

AspenBio Pharma's EVP & General Counsel just picked up 984,942 shares - Sept. 29, 2022

AspenBio Pharma director just picked up 123,941 shares - Sept. 29, 2022

AspenBio Pharma's Chief Executive Officer just picked up 3,373,435 shares - Sept. 29, 2022

AspenBio Pharma director just picked up 117,691 shares - Sept. 29, 2022

AspenBio Pharma's CFO just declared owning 6,285 shares of AspenBio Pharma - Sept. 28, 2022

AspenBio Pharma director just picked up 117,691 shares - Sept. 28, 2022

AspenBio Pharma's SVP & CAO (See Remarks) just declared owning 22,333 shares of AspenBio Pharma - Sept. 28, 2022

AspenBio Pharma's Executive Chairman just disposed of 3,301,686 shares - Sept. 28, 2022

Other preliminary proxy statements - Sept. 23, 2022

Except as presented in this - Sept. 23, 2022

Securities to be offered to employees in employee benefit plans - Sept. 23, 2022

AspenBio Pharma's Chief Financial Officer just picked up 5,703 shares - Sept. 14, 2022

AspenBio Pharma's EVP & General Counsel just picked up 27,658 shares - Sept. 14, 2022

AspenBio Pharma director just disposed of 10,000 shares - Sept. 2, 2022

AspenBio Pharma director just picked up 11,250 shares - Aug. 31, 2022

AspenBio: Riot Reports Second Quarter 2022 Financial Results, Current Operational And Financial Highlights - Aug. 16, 2022

AspenBio Pharma Just Filed Its Quarterly Report: Income (Loss) Per Sh... - Aug. 15, 2022

AspenBio Pharma's EVP & General Counsel just picked up 6,000 shares - Aug. 3, 2022

As described in Item - Aug. 2, 2022

On July - July 26, 2022

AspenBio: Soliciting Material Under Section 240.14A-12 RIOT BLOCKCHAIN, INC. - July 26, 2022

EVP of AspenBio Pharma just picked up 19,942 shares - July 21, 2022

AspenBio Pharma's Chief Financial Officer was just granted 14,666 restricted shares - July 18, 2022

AspenBio Pharma's Chief Executive Officer just declared 46,666 restricted shares - July 18, 2022

AspenBio Pharma's See Remarks was just granted 12,000 restricted shares - July 18, 2022

AspenBio Pharma's Chief Executive Officer was just granted 16,666 restricted shares - July 15, 2022

AspenBio Pharma's Executive Chairman was just granted 16,666 restricted shares - July 15, 2022

AspenBio Pharma's EVP & General Counsel was just granted 12,000 restricted shares - July 15, 2022

AspenBio Pharma's Chief Executive Officer was just granted 16,666 restricted shares - July 15, 2022

EVP of AspenBio Pharma was just granted 12,000 restricted shares - July 15, 2022

AspenBio Pharma's [See Remarks] just picked up 28,934 shares - July 15, 2022

AspenBio: Soliciting Material Under Section 240.14A-12 RIOT BLOCKCHAIN, INC. - July 11, 2022

AspenBio: Soliciting Material Under Section 240.14A-12 RIOT BLOCKCHAIN, INC. - July 8, 2022

AspenBio: Soliciting Material Under Section 240.14A-12 RIOT BLOCKCHAIN, INC. - July 8, 2022

AspenBio: Form, Schedule Or Registration Statement No Filing Party: Date Filed: - July 5, 2022

AspenBio: Form, Schedule Or Registration Statement No Filing Party: Date Filed: - July 1, 2022

AspenBio: Form, Schedule Or Registration Statement No Filing Party: Date Filed: - June 27, 2022

Additional definitive proxy soliciting materials and Rule 14(a)(12) material - June 17, 2022

Other definitive proxy statements - June 17, 2022

On June - June 17, 2022

AspenBio: Form, Schedule Or Registration Statement No Filing Party: Date Filed: - June 17, 2022

AspenBio Pharma's [See Remarks] just picked up 17,500 shares - June 16, 2022

Preliminary Proxy Soliciting materials - June 15, 2022

Other preliminary proxy statements - June 7, 2022

AspenBio: Riot Blockchain Announces Cfo Transition Plan - June 6, 2022

AspenBio Pharma's Chief Financial Officer just picked up 46,020 shares - May 19, 2022

AspenBio Pharma's [See Remarks] just picked up 17,500 shares - May 19, 2022

On May - May 18, 2022

AspenBio Pharma Just Filed Its Quarterly Report: Income Per Share:Bas... - May 10, 2022

Annual report [Section 13 and 15(d), not S-K Item 405] - May 2, 2022

AspenBio Pharma's [See remarks] just picked up 16,100 shares - April 22, 2022

AspenBio Pharma's Chief Financial Officer was just granted 24,000 restricted shares - April 15, 2022

AspenBio Pharma's see Remarks was just granted 14,000 restricted shares - April 15, 2022

AspenBio Pharma's General Counsel was just granted 14,000 restricted shares - April 15, 2022

AspenBio Pharma's Executive Chairman was just granted 30,000 restricted shares - April 15, 2022

AspenBio Pharma's see Remarks was just granted 14,000 restricted shares - April 15, 2022

AspenBio Pharma's [See Remarks] was just granted 20,000 restricted shares - April 15, 2022

AspenBio Pharma's Chief Executive Officer was just granted 30,000 restricted shares - April 15, 2022

AspenBio Pharma's Chief Operating Officer was just granted 75,000 restricted shares - April 8, 2022

AspenBio Pharma director just disposed of 2,500 shares - April 8, 2022

On March - March 23, 2022

AspenBio Pharma director just picked up 2,500 shares - March 21, 2022

AspenBio Pharma director just picked up 2,500 shares - March 18, 2022

AspenBio: Riot Blockchain Announces Financial Results And Operating Highlights For The Year Ended December 31, 2021 - March 18, 2022

AspenBio Pharma director just picked up 2,500 shares - March 18, 2022

AspenBio Pharma director just picked up 1,250 shares - March 18, 2022

AspenBio Pharma's General Counsel just picked up 1,595 shares - March 18, 2022

AspenBio Pharma Just Filed Its Annual Report: Income (loss) Per S... - March 16, 2022

Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 - March 1, 2022

AspenBio Pharma's Chief Operating Officer just picked up 30,100 shares - Feb. 22, 2022

AspenBio Pharma's Executive Chairman just picked up 174,446 shares - Feb. 22, 2022

AspenBio: Year Ended December 31, 2020 FERRIE FRANZMANN INDUSTRIES Denver, Colorado COMBINED FINANCIAL STATEMENTS - Feb. 16, 2022

Susquehanna Securities, LLC just provided an update on share ownership of AspenBio Pharma - Feb. 14, 2022

The Vanguard Group just provided an update on share ownership of AspenBio Pharma - Feb. 10, 2022

Effective as of February - Feb. 8, 2022

On January - Jan. 18, 2022

AspenBio Pharma's General Counsel was just granted 36,000 restricted shares - Jan. 18, 2022

AspenBio Pharma's see Remarks just picked up 31,141 shares - Jan. 18, 2022

AspenBio Pharma's Executive Chairman was just granted 50,000 restricted shares - Jan. 18, 2022

AspenBio Pharma's see Remarks just picked up 31,141 shares - Jan. 18, 2022

AspenBio Pharma's Chief Financial Officer was just granted 44,000 restricted shares - Jan. 18, 2022

AspenBio Pharma's Chief Executive Officer was just granted 50,000 restricted shares - Jan. 18, 2022

Sorry, no schedule available for this company

 


Feedback